YiChang HEC ChangJiang Pharmaceutical Co. Ltd. | |
Stock Exchange | Hong Kong Stock Exchange |
EPS |
HKD2.5 |
Market Cap |
HKD18.65 B |
Shares Outstanding |
226.2 M |
Public Float |
130.89 M |
Address |
Dong YangGuang Park Dongguan Guangdong 443300 China |
Employees | - |
Website | http://www.hec-changjiang.com |
Updated | 07/08/2019 |
YiChang HEC ChangJiang Pharmaceutical Co. Ltd. engages in the development, manufacturing and selling of pharmaceutical products in the therapeutic areas of anti-virus, endocrine and metabolic diseases, cardiovascular diseases and others. Its products include Benzbromarone, Telmisartan, Amlodipine besylate, and Cetirizine hydrochloride. The company was founded on May 11, 2015 and is headquartered in Dongguan, China. |